Formation Bio Lands $372M Series D Amid AI-Driven Expansionby Lilu Anderson 26.06.2024Formation Bio secures $372M Series D led by Sanofi to enhance AI-driven drug development, focusing on workflow automation and AI ...
Vallourec to Showcase at Major Hydrogen & Carbon Capture Eventsby Lilu Anderson 26.06.2024Vallourec to showcase innovations in hydrogen and carbon capture at Houston conferences, June 26-27, 2024. Attendees include key decarbonization players.
FactSet Q3 2024 Earnings: 5% Growth in ASV and Servicesby Mark Eisenberg 24.06.2024FactSet’s Q3 fiscal 2024 earnings report shows growth in subscription value and EPS, with a 39.4% operating margin amid market ...
Oil Prices Dip as Strong Dollar Pressures Commodities Marketby Mark Eisenberg 24.06.2024Oil prices ease amidst a stronger dollar and potential higher interest rates, despite support from geopolitical tensions and OPEC+ supply ...
Sony Slashes VR Investment: Only Two Games in the Pipelineby Mark Eisenberg 21.06.2024Sony reportedly cuts VR game investments; only two first-party VR games in PSVR2 pipeline, casting doubts on future support and ...
Top Generative AI Courses in 2024: Learn, Build, Innovateby Lilu Anderson 19.06.2024Explore the top 2024 generative AI courses transforming creative tasks, covering LLMs, practical uses, and prompt engineering for career advancement.
Day One Biopharma Expands to ADCs with $55M Drug Acquisitionby Lilu Anderson 19.06.2024"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
Meta Quest Outpaces Apple Vision Pro With AR Deviceby Lilu Anderson 18.06.2024Meta's Quest beats Apple Vision Pro with the MX Ink Stylus, enhancing AR/VR capabilities on Quest 2 & 3, signaling ...
Colonial Pipeline Owners Eye Stake Sales Amid $10B Valuationby Mark Eisenberg 18.06.2024Owners of Colonial Pipeline, valued over $10B, explore selling stakes amid rising U.S. energy demand; past cyberattack highlights vulnerabilities.
Roche’s Hemlibra Battles Fierce Competition Amid Rating Holdby Mark Eisenberg 17.06.2024Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...